Help | RSS Feed

TG Therapeutics, Inc. (NASD:TGTX) Seasonal Chart

TG Therapeutics, Inc. (NASD:TGTX) Seasonality

TGTX Relative to the S&P 500
TGTX Relative to the S&P 500

TGTX Relative to the Sector
TGTX Relative to the Sector

Monthly Seasonal TG Therapeutics, Inc. (NASD:TGTX)

Seasonal Chart Analysis

Analysis of the TG Therapeutics, Inc. (NASD:TGTX) seasonal charts above shows that a Buy Date of December 29 and a Sell Date of March 22 has resulted in a geometric average return of 52.9% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 152.9% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the
acquisition, development & commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore